
The pharmaceutical industry has an obligation to identify adverse reactions to drug products during all zzso of drug development, including the zzso zzso Estimates of population exposure to pharmaceutical products are important to the zzso surveillance of drugs, and provide a context for assessing the various risks and benefits, including drug safety, associated with drug zzso This paper describes a systematic approach to zzso zzso drug exposure using zzso shipment data to estimate the quantity of medication available, and dosage information zzso by indication or other factors as zzso to convert the quantity of medication to person time of zzso Unlike the zzso methods often used to estimate exposure, this approach provides estimates whose calculations are zzso zzso and consistent across products and over zzso The methods can readily be carried out by an individual or small group specializing in this function, and lend themselves to zzso The present zzso approach is practical and relatively uncomplicated to zzso We believe it is a useful zzso 

